Nephrocast-V:一个深度学习模型用于预测使用电子健康记录数据预测万科米辛度
Ghodsieh Ghanbari1, Craig Stevens2, Eliah Aronoff-Spencer3,4
1Department of Biomedical Informatics, University of California San Diego (UCSD) School of Medicine, La Jolla, California, USA.
Pharmacotherapy
|September 30, 2025
概括
一个深度学习模型可以预测危急病患者的万科米辛最低度,有助于最佳剂量. 这种人工智能方法支持个性化的万科米辛治疗,并改善患者的治疗结果.
科学领域:
- 药理学和计算医学 药理学和计算医学
- 医疗保健中的人工智能
- 关键护理医学 关键护理医学
背景情况:
- 范科米对于治疗严重的グラム阳性细菌感染至关重要,包括耐甲基西林的金黄色葡萄球菌.
- 达到和维持治疗性万科米辛最低度是临床上具有挑战性的,影响治疗疗效.
- 个性化剂量对于优化危重病患者的万科米辛治疗至关重要.
研究的目的:
- 开发和验证一种深度学习模型,以提前2天预测万科米的最低度.
- 评估该模型能够推最佳的万科米辛剂量调整的能力.
- 支持在重症监护室 (ICU) 患者中对万科米辛进行个性化治疗药物监测.
主要方法:
- 利用了来自ICU患者 (2016-2024) 的电子健康记录 (EHR) 数据.
- 设计了一个深度学习模型,结合了长短期记忆 (LSTM) 和多头注意层.
- 纳入患者的人口统计,生命体征,实验室,药物和剂量史作为模型特征.
主要成果:
- 深度学习模型的平均绝对误差 (MAE) 为3.15 mg/L,根平均平方误差 (RMSE) 为4.17 mg/L.
- 模型的性能与使用贝叶斯剂量软件的重症监护药剂师的性能相当.
- 不遵守基于模型的剂量建议与非治疗性万科米辛水平相关.
结论:
- 深度学习模型显示了个性化科米辛治疗药物监测的巨大潜力.
- 人工智能驱动的预测可以帮助临床医生优化万科米辛剂量策略.
- 这种方法可以提高在重症监护机构的万科米辛治疗的有效性和安全性.
相关概念视频
Estimation of k and VD of Aminoglycosides
185
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
185
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
204
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
204
Drug Concentration Versus Time Correlation
1.9K
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
1.9K
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
209
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
209
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
288
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
288
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
451
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
451

